{"id":479013,"date":"2025-10-06T22:01:21","date_gmt":"2025-10-06T22:01:21","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/479013\/"},"modified":"2025-10-06T22:01:21","modified_gmt":"2025-10-06T22:01:21","slug":"onemednet-teams-up-with-palantir-to-supercharge-ai-in-healthcare","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/479013\/","title":{"rendered":"OneMedNet Teams Up With Palantir To Supercharge AI In Healthcare"},"content":{"rendered":"\n<p class=\"yf-1090901\"><strong>OneMedNet Corp <\/strong>(NASDAQ:<a class=\"link \" href=\"http:\/\/finance.yahoo.com\/q?s=ONMD\" data-ylk=\"slk:ONMD;elm:context_link;itc:0;sec:content-canvas\" target=\"_blank\" rel=\"noopener\">ONMD<\/a>) shares rocketed premarket on Monday after the company disclosed that it has chosen <strong>Palantir Technologies Inc.<\/strong> (NASDAQ:<a class=\"link \" href=\"http:\/\/finance.yahoo.com\/q?s=PLTR\" data-ylk=\"slk:PLTR;elm:context_link;itc:0;sec:content-canvas\" target=\"_blank\" rel=\"noopener\">PLTR<\/a>) to <a href=\"https:\/\/www.benzinga.com\/pressreleases\/25\/10\/g48037581\/onemednet-selects-palantir-to-advance-healthcare-ai-and-data-analytics?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=site&amp;nid=48039639\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:advance its healthcare AI;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">advance its healthcare AI<\/a> and real-world data analytics operations.<\/p>\n<p class=\"yf-1090901\">OneMedNet is leveraging Palantir\u2019s analytics to unlock the $868 billion AI healthcare market by 2030 through secure, scalable data-driven solutions.<\/p>\n<p class=\"yf-1090901\">Under the multi-year partnership, Palantir\u2019s Artificial Intelligence Platform, which is known for integrating complex datasets and delivering real-time insights, will connect with OneMedNet\u2019s network.<\/p>\n<p class=\"yf-1090901\"><strong>Read Next: <a href=\"https:\/\/www.benzinga.com\/news\/topics\/25\/10\/48032268\/outreach-palantir-and-salesforce-veterans-raise-21m-for-paid-ai-to-end-seat-based-saas-billing-with-ai-agent-infrastructure?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=site&amp;nid=48039639\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Outreach, Palantir, And Salesforce Veterans Raise $21M For Paid.ai To End Seat-Based SaaS Billing With AI Agent Infrastructure;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Outreach, Palantir, And Salesforce Veterans Raise $21M For Paid.ai To End Seat-Based SaaS Billing With AI Agent Infrastructure<\/a><\/strong><\/p>\n<p class=\"yf-1090901\">The network offers access to over 5 billion administrative claims and 131 million clinical exams across more than 1,750 provider sites.<\/p>\n<p class=\"yf-1090901\">The collaboration spans key therapeutic areas including oncology, cardiology, and rare diseases.<\/p>\n<p class=\"yf-1090901\">Using Palantir\u2019s Artificial Intelligence Platform, OneMedNet will power its iRWD near real-time AI-enabled provider network.<\/p>\n<p class=\"yf-1090901\">The platform will provide life sciences, medical device, and research organizations with access to anonymized, regulatory-grade clinical data and advanced analytics, accelerating the development of next-generation medical innovations.<\/p>\n<p class=\"yf-1090901\"><strong>Aaron Green<\/strong>, President and CEO of OneMedNet, stated, \u201cPalantir\u2019s AIP helps us revolutionize our ability to deliver high-quality, regulatory-compliant data at remarkable speed. This positions us to power breakthroughs in clinical research and AI-driven healthcare solutions.\u201d<\/p>\n<p class=\"yf-1090901\"><strong>Price Action:<\/strong> ONMD shares were trading higher by 46.60% to $1.510\u00a0premarket at last check Monday.<\/p>\n<p class=\"yf-1090901\"><strong>Read Next:<\/strong><\/p>\n<p class=\"yf-1090901\">Photo by Michael Vi via Shutterstock<\/p>\n<p class=\"yf-1090901\">UNLOCKED: 5 NEW TRADES EVERY WEEK. <a href=\"https:\/\/www.benzinga.com\/premium\/ideas\/benzinga-edge-checkout\/?t=be8be9spja3yaad2&amp;utm_source=yahoo\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Click now to get top trade ideas daily;elm:context_link;itc:0;sec:content-canvas\" class=\"link \"><strong>Click now to get top trade ideas daily<\/strong><\/a>, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets.<\/p>\n<p class=\"yf-1090901\">Get the latest stock analysis from Benzinga?<\/p>\n<p class=\"yf-1090901\">This article <a href=\"https:\/\/www.benzinga.com\/trading-ideas\/movers\/25\/10\/48039639\/onemednet-teams-up-with-palantir-to-supercharge-ai-in-healthcare\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:OneMedNet Teams Up With Palantir To Supercharge AI In Healthcare;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">OneMedNet Teams Up With Palantir To Supercharge AI In Healthcare<\/a> originally appeared on <a href=\"https:\/\/www.benzinga.com\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Benzinga.com;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Benzinga.com<\/a><\/p>\n<p class=\"yf-1090901\">\u00a9 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.<\/p>\n","protected":false},"excerpt":{"rendered":"OneMedNet Corp (NASDAQ:ONMD) shares rocketed premarket on Monday after the company disclosed that it has chosen Palantir Technologies&hellip;\n","protected":false},"author":2,"featured_media":479014,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4316],"tags":[1942,105,4348,159018,159017,159016,23213,16,15],"class_list":{"0":"post-479013","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-artificial-intelligence","9":"tag-health","10":"tag-healthcare","11":"tag-healthcare-ai","12":"tag-healthcare-market","13":"tag-onemednet-corp","14":"tag-palantir-technologies","15":"tag-uk","16":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115329478373645361","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/479013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=479013"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/479013\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/479014"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=479013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=479013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=479013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}